Recurrent DIPG
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas (NCT06838676) | Nationwide Children's Hospital | 2025-07-10 |
Track Recurrent DIPG automatically
Every clearance here is in the API, with alerts when new ones post.